Drug Shortage Report for APRESOLINE

Last updated on 2020-11-18 History
Report ID 91935
Drug Identification Number 00723754
Brand name APRESOLINE
Common or Proper name HYDRALAZINE HYDROCHLORIDE FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) HYDRALAZINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code C02DB
ATC description ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-21
Estimated end date 2021-01-25
Actual end date
Shortage status Actual shortage
Updated date 2020-11-18
Company comments Product is on 100% allocation at McKesson.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-11-18 French Compare
v11 2020-11-18 English Compare
v10 2020-11-04 French Compare
v9 2020-11-04 English Compare
v8 2020-09-30 French Compare
v7 2020-09-30 English Compare
v6 2020-09-09 French Compare
v5 2020-09-09 English Compare
v4 2019-08-22 English Compare
v3 2019-08-19 French Compare
v2 2019-08-19 English Compare
v1 2019-08-19 English Compare